MoneyWorks4Me

Bajaj Healthcare - Quaterly Results

18 Oct 2026 Evaluate
The revenue for the September 2026 quarter is pegged at Rs. 1759.02 millions, about 18.92% up against Rs. 1479.15 millions recorded during the year-ago period.Net profit stood at Rs. 143.81  millions  compared to Rs. 124.48 millions in the corresponding previous quarter,high by 15.53%.Operating Profit saw a handsome growth to 321.01 millions from 286.03 millions in the quarter ended September 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 1759.02 1479.15 18.92 3415.34 2967.51 15.09 6110.31 5426.02 12.61
Other Income 8.92 16.53 -46.04 17.03 25.31 -32.71 71.34 194.04 -63.23
PBIDT 321.01 286.03 12.23 616.64 539.91 14.21 1119.51 1018.31 9.94
Interest 59.75 55.59 7.48 120.66 107.85 11.88 222.34 279.04 -20.32
PBDT 261.26 230.44 13.37 495.98 432.06 14.79 564.70 739.27 -23.61
Depreciation 76.49 70.82 8.01 146.63 127.18 15.29 275.48 279.18 -1.33
PBT 184.77 159.62 15.76 349.35 304.88 14.59 289.22 460.09 -37.14
TAX 40.96 35.14 16.56 66.62 58.65 13.59 76.13 30.79 147.26
Deferred Tax 40.96 35.14 16.56 66.62 58.65 13.59 76.13 30.79 147.26
PAT 143.81 124.48 15.53 282.73 246.23 14.82 213.09 429.30 -50.36
Equity 168.33 157.92 6.59 168.33 157.92 6.59 168.31 157.92 6.58
PBIDTM(%) 18.25 19.34 -5.63 18.06 18.19 -0.76 18.32 18.77 -2.37
Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1224.50
Cipla 1337.00
Lupin 1925.00
Zydus Lifesciences 1127.85
View more..